These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 36937127)

  • 21. Fibroblast growth factor 23 and the antiproteinuric response to dietary sodium restriction during renin-angiotensin-aldosterone system blockade.
    Humalda JK; Lambers Heerspink HJ; Kwakernaak AJ; Slagman MC; Waanders F; Vervloet MG; Ter Wee PM; Navis G; de Borst MH;
    Am J Kidney Dis; 2015 Feb; 65(2):259-66. PubMed ID: 25278093
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Salt reduction and hypertension in China: a concise state-of-the-art review.
    Liu Y; Li H; Hong S; Yin X
    Cardiovasc Diagn Ther; 2015 Jun; 5(3):191-6. PubMed ID: 26090330
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Discrepancy: Calcium Channel Blockers Are Effective for the Treatment of Hypertensive Left Ventricular Hypertrophy but Not as Effective for Prevention of Heart Failure.
    Koracevic G; Perisic Z; Stanojkovic M; Stojanovic M; Zdravkovic M; Tomasevic M; Djordjevic D; Mladenovic K; Koracevic M; Trkulja J
    Med Princ Pract; 2022; 31(5):454-462. PubMed ID: 36044874
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increased Dietary Salt Changes Baroreceptor Sensitivity and Intrarenal Renin-Angiotensin System in Goldblatt Hypertension.
    Shimoura CG; Lincevicius GS; Nishi EE; Girardi AC; Simon KA; Bergamaschi CT; Campos RR
    Am J Hypertens; 2017 Jan; 30(1):28-36. PubMed ID: 27629265
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interpreting stimulated plasma renin and aldosterone to select physiologically individualized therapy for resistant hypertension: importance of the class of stimulating drugs.
    Huang X; Li J; Liu L; Chen G; Yi Y; Li P; Wu Y; Xu Y; Bao H; Yu L; Qin X; Zhang Y; Wang B; Li J; Fan Hou F; Huo Y; Cheng X; Spence JD
    Hypertens Res; 2019 Dec; 42(12):1971-1978. PubMed ID: 31562418
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Beta-adrenergic receptor blockade as a therapeutic approach for suppressing the renin-angiotensin-aldosterone system in normotensive and hypertensive subjects.
    Blumenfeld JD; Sealey JE; Mann SJ; Bragat A; Marion R; Pecker MS; Sotelo J; August P; Pickering TG; Laragh JH
    Am J Hypertens; 1999 May; 12(5):451-9. PubMed ID: 10342782
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influence of antihypertensive medication on aldosterone and renin concentration in the differential diagnosis of essential hypertension and primary aldosteronism.
    Seifarth C; Trenkel S; Schobel H; Hahn EG; Hensen J
    Clin Endocrinol (Oxf); 2002 Oct; 57(4):457-65. PubMed ID: 12354127
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The renin-angiotensin-aldosterone system: a specific target for hypertension management.
    Weir MR; Dzau VJ
    Am J Hypertens; 1999 Dec; 12(12 Pt 3):205S-213S. PubMed ID: 10619573
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Green tea could improve elderly hypertension by modulating arterial stiffness, the activity of the renin/angiotensin/aldosterone axis, and the sodium-potassium pumps in old male rats.
    Gao J; Akbari A; Wang T
    J Food Biochem; 2022 Dec; 46(12):e14398. PubMed ID: 36181277
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Beta-blockers and inhibitors of the renin-angiotensin aldosterone system for chronic heart failure with preserved ejection fraction.
    Martin N; Manoharan K; Thomas J; Davies C; Lumbers RT
    Cochrane Database Syst Rev; 2018 Jun; 6(6):CD012721. PubMed ID: 29952095
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of enalapril, tempol, and eplerenone on salt-induced hypertension in dahl salt-sensitive rats.
    Bayorh MA; Mann G; Walton M; Eatman D
    Clin Exp Hypertens; 2006 Feb; 28(2):121-32. PubMed ID: 16546838
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of sodium-glucose cotransporter-2 inhibitors and aldosterone antagonists, in addition to renin-angiotensin system antagonists, on major adverse kidney outcomes in patients with type 2 diabetes and chronic kidney disease: A systematic review and network meta-analysis.
    Yang S; Zhao L; Mi Y; He W
    Diabetes Obes Metab; 2022 Nov; 24(11):2159-2168. PubMed ID: 35712807
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Low-dose aldosterone blockade as a new treatment paradigm for controlling resistant hypertension.
    Calhoun DA
    J Clin Hypertens (Greenwich); 2007 Jan; 9(1 Suppl 1):19-24. PubMed ID: 17215651
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pooled Analysis of Multiple Crossover Trials To Optimize Individual Therapy Response to Renin-Angiotensin-Aldosterone System Intervention.
    Petrykiv SI; Laverman GD; Persson F; Vogt L; Rossing P; de Borst MH; Gansevoort RT; de Zeeuw D; Heerspink HJL
    Clin J Am Soc Nephrol; 2017 Nov; 12(11):1804-1813. PubMed ID: 29021336
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hypertension: renin-angiotensin-aldosterone system alterations.
    Te Riet L; van Esch JH; Roks AJ; van den Meiracker AH; Danser AH
    Circ Res; 2015 Mar; 116(6):960-75. PubMed ID: 25767283
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of the renin-angiotensin-aldosterone system in cardiovascular homeostasis in normal human subjects.
    Sancho J; Re R; Burton J; Barger AC; Haber E
    Circulation; 1976 Mar; 53(3):400-5. PubMed ID: 174834
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Activation of the Renin-Angiotensin system mediates the effects of dietary salt intake on atherogenesis in the apolipoprotein E knockout mouse.
    Tikellis C; Pickering RJ; Tsorotes D; Huet O; Chin-Dusting J; Cooper ME; Thomas MC
    Hypertension; 2012 Jul; 60(1):98-105. PubMed ID: 22647892
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Management of hypertension in diabetes mellitus.
    Alzahrani AS
    Expert Rev Endocrinol Metab; 2007 May; 2(3):341-357. PubMed ID: 30743805
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Renin angiotensin aldosterone inhibition in the treatment of cardiovascular disease.
    Ferrario CM; Mullick AE
    Pharmacol Res; 2017 Nov; 125(Pt A):57-71. PubMed ID: 28571891
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dysregulation of angiotensin II synthesis is associated with salt sensitivity in the spontaneous hypertensive rat.
    Hodge G; Ye VZ; Duggan KA
    Acta Physiol Scand; 2002 Mar; 174(3):209-15. PubMed ID: 11906319
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.